Hepatocellular carcinoma highlights from ASCO and WCGIC 2021

Episode 1 • July 16, 2021 • 00:12:16
Hepatocellular carcinoma highlights from ASCO and WCGIC 2021
COR2ED Medical Education
Hepatocellular carcinoma highlights from ASCO and WCGIC 2021

Jul 16 2021 | 00:12:16

/

Show Notes

In this episode, Dr Choo discusses some key abstracts presented during the virtual ASCO and WCGIC congresses in 2021.

Dr Choo comments that despite the promising and positive data with hepatic arterial infusion chemotherapy (HAIC) in two different Phase 3 trials settings, the impact on clinical practice is still questionable.

Dr Choo reviews some updated data from IMbrave150 which is the study that validated atezolizumab+bevacizumab combination as the new standard of care in 1L setting for aHCC patients. In addition, real-world data from OPTIMIS and GIDEON studies, confirmed that sorafenib has still a role to play in 1L specifically in Child-Pugh B patients.

Dr Choo emphasises that biomarkers are urgently needed in HCC and summarises several studies investigating potential biomarkers that would require further investigation prior to clinical practice validation.

Finally, Dr Choo completes the overview by presenting a Japanese study that provides support for radio frequency ablation as an option, apart from surgery for patients with small HCC.

Other Episodes

Episode 1

September 08, 2021 • 00:12:56
Episode Cover

Nurse management of AEs in patients receiving VEGFR-TKIs

In this podcast, Veerle Lamotte, an oncology nurse practitioner at Antwerp University Hospital and Paola Belardi, nurse chief at San Donato Hospital in Arezzo,...

Listen

Episode 15

July 13, 2023 • 00:27:27
Episode Cover

Non-metastatic gastric and GEJ cancers: clinical case discussions ep.1

COR2ED Medical Education: This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth...

Listen

Episode

October 25, 2023 • 00:25:38
Episode Cover

VTE: how long should anti-thrombotic treatment be?

COR2ED Medical Education: Extended anticoagulation beyond the initial 3 months is indicated for all types of VTE, except in surgery-or trauma-VTE or in patients...

Listen